The CFAR Molecular Diversity Core was initiated in 1995 to provide a DNA sequencing service to support the AIDS research community. It evolved into the current Genomics Core with a new focus on providing assistance in assuring HIV sequence quality control and in performing detailed phylogenetic and bioinformatic analyses. Since its inception, the Core has contributed to ten or more collaborative, peerreviewed publications per year. Going forward, we will continue to develop, refine, implement, support and teach methods for the study of HIV gene sequences. However, we will also broaden the scope of the core in ways that together make Computational Biology, rather than Genomics, the most apt description of our new Core. First, we will create an open-source bioinformatics toolkit that includes incorporation of existing analytical tools together with emerging techniques. This toolkit is being developed in collaboration with the local CFAR Biostatistics Core, the Los Alamos National Laboratory (LANL) and investigators at the UCSD CFAR. Second, we will expand our efforts at training and research community outreach. To this end we will develop a unified web-based interface to access our analysis tools, using questionnaires to determine need for tool development and training sessions. We will develop an easier mechanism for users to ask specific questions or request specific support for both existing tool usage and possibly additional novel analyses. Lastly, we will produce a regular Newsletter to inform the CFAR community of the availability and functionality of our computational tools and similar programs from other sources. Third, our CFAR efforts will link and assist parallel and separately funded efforts to develop a database to acquire, retain and mine clinical, laboratory and genetic data derived from HIV and infected human hosts. These database and mining tools are being developed, implemented and will be spread to investigators throughout the international CFAR community and other AIDS researchers. Development is proceeding through collaboration with all of the major laboratories gathering viral gene sequence data, leaders of those gathering AIDS-related clinical, therapy, host genetics and viral immunology data, as well as those leading in the area of integrated data analysis. These include investigators at the UW, LANL, six CFARs that focus on a combination of these areas, as well as the Multicenter AIDS Cohort Study (MACS), the Center for HIV-AIDS Vaccine Immunology (CHAVI), and the Collaborative AIDS Vaccine Discovery (CAVD) and Partners in Prevention (PIP) programs funded by the Bill and Melinda Gates foundation.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI027757-23
Application #
8080968
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2010-06-01
Budget End
2011-05-31
Support Year
23
Fiscal Year
2010
Total Cost
$162,093
Indirect Cost
Name
University of Washington
Department
Type
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Bengtson, Angela M; Pence, Brian W; Eaton, Ellen F et al. (2018) Patterns of efavirenz use as first-line antiretroviral therapy in the United States: 1999-2015. Antivir Ther 23:363-372
Fredericksen, Rob J; Mayer, Kenneth H; Gibbons, Laura E et al. (2018) Development and Content Validation of a Patient-Reported Sexual Risk Measure for Use in Primary Care. J Gen Intern Med 33:1661-1668
Wilson, Kate S; Wanje, George; Masese, Linnet et al. (2018) A Prospective Cohort Study of Fertility Desire, Unprotected Sex, and Detectable Viral Load in HIV-Positive Female Sex Workers in Mombasa, Kenya. J Acquir Immune Defic Syndr 78:276-282
Ikoma, Minako; Gantt, Soren; Casper, Corey et al. (2018) KSHV oral shedding and plasma viremia result in significant changes in the extracellular tumorigenic miRNA expression profile in individuals infected with the malaria parasite. PLoS One 13:e0192659
Grover, Surbhi; Desir, Fidel; Jing, Yuezhou et al. (2018) Reduced Cancer Survival Among Adults With HIV and AIDS-Defining Illnesses Despite No Difference in Cancer Stage at Diagnosis. J Acquir Immune Defic Syndr 79:421-429
Gómez, Laurén A; Crowell, Claudia S; Njuguna, Irene et al. (2018) Improved Neurodevelopment After Initiation of Antiretroviral Therapy in Human Immunodeficiency Virus-infected Children. Pediatr Infect Dis J 37:916-922
Thomson, Kerry A; Dhanireddy, Shireesha; Andrasik, Michele et al. (2018) Fertility desires and preferences for safer conception strategies among people receiving care for HIV at a publicly-funded clinic in Seattle, WA. AIDS Care 30:121-129
Lohman-Payne, Barbara; Gabriel, Benjamin; Park, Sangshin et al. (2018) HIV-exposed uninfected infants: elevated cord blood Interleukin 8 (IL-8) is significantly associated with maternal HIV infection and systemic IL-8 in a Kenyan cohort. Clin Transl Med 7:26
McGrath, Christine J; Singa, Benson; Langat, Agnes et al. (2018) Non-disclosure to male partners and incomplete PMTCT regimens associated with higher risk of mother-to-child HIV transmission: a national survey in Kenya. AIDS Care 30:765-773
Njuguna, Irene N; Wagner, Anjuli D; Omondi, Vincent O et al. (2018) Financial Incentives for Pediatric HIV Testing in Kenya. Pediatr Infect Dis J 37:1142-1144

Showing the most recent 10 out of 1275 publications